
MannKind Corp
MNKDHealthcare|Biotechnology|USA
$4.09
-0.05 (-1.21%)
Analyst Estimates
annual
{
"date": [
"202612",
"202712",
"202812",
"202912",
"203012"
],
"revenue_estimate": [
462.51,
521.8,
535.1,
607.4,
702.48
],
"ebit_estimate": [
57.41,
97.11,
93.36,
151.74,
225.91
],
"ebitda_estimate": [
null,
null,
null,
null,
null
],
"net_income_estimate": [
-4.97,
45.41,
47.49,
94.21,
152.62
],
"per_share_eps_estimate": [
0,
0.14,
0.14,
0.28,
0.45
],
"eps_nri_estimate": [
0,
0.14,
0.14,
0.28,
0.45
],
"dividend_estimate": [
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
-3.27,
43.04,
39.55,
106.6,
200.84
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
75.3,
76.93,
77.73,
76.65,
75.5
],
"operating_cash_flow_estimate": [
null,
null,
null,
null,
null
],
"pettm_estimate": [
0,
30.07,
28.4,
14.56,
9.03
],
"long_term_growth_rate_mean": 0,
"long_term_revenue_growth_rate_mean": "15.06",
"future_per_share_eps_estimate_growth": null,
"future_eps_nri_estimate_growth": null,
"future_revenue_estimate_growth": 15.06,
"future_ebit_estimate_growth": 37.16,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": 1.85,
"future_operating_cash_flow_per_share_estimate_growth": null
}
quarterly
{
"date": [
"202606",
"202609",
"202612",
"202703",
"202706",
"202709",
"202712"
],
"revenue_estimate": [
109.37,
120.46,
140.76,
120,
144,
153,
153
],
"ebit_estimate": [
11.84,
18.38,
26.86,
8,
58,
65,
25
],
"ebitda_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"net_income_estimate": [
-0.56,
3.86,
10.24,
-3,
47,
53,
18
],
"per_share_eps_estimate": [
0,
0.01,
0.03,
-0.01,
0.15,
0.17,
0.06
],
"eps_nri_estimate": [
0,
0.01,
0.03,
-0.01,
0.15,
0.17,
0.06
],
"dividend_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
0.31,
2.36,
10.95,
-1,
49,
56,
16
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
73.8,
74.1,
74.57,
null,
null,
null,
null
],
"operating_cash_flow_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"pettm_estimate": [
136.33,
22.72,
12.06,
11.05,
null,
null,
null
],
"long_term_growth_rate_mean": 0,
"long_term_revenue_growth_rate_mean": "15.06",
"future_per_share_eps_estimate_growth": null,
"future_eps_nri_estimate_growth": null,
"future_revenue_estimate_growth": 15.06,
"future_ebit_estimate_growth": 37.16,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": 1.85,
"future_operating_cash_flow_per_share_estimate_growth": null
}